Therapeutic Delivery – News and Features

The collaboration will use Novosom’s proprietary Smarticles® for in vivo siRNA delivery.

pSivida has entered into agreements to evaluate its platform technology for pharmaceutical companies’ developmental compounds.

Use of nanotechnology in medicine will make a major impact on healthcare in the 21st century.

Hopkins also plans to announce the formation of a separate nanomedicine research institute.

Findings describe how natural nanoparticles can be adapted to fight cancer.

The patent covers the manufacture of multifunctional nano- and micron-sized capsules.

Initiative will bring together industry, government and academic experts to drive nanobiology innovation.

Alcon and Dharmacon will select and prioritise disease-related gene targets.

Capsulution will receive funding of EUR 600,000 over a period of 3 years.

The studies aim at increasing the bioavailability of several new chemical entities in the human body.